NuCana (NCNA) Other Operating Expenses (2018 - 2022)
NuCana (NCNA) reported Other Operating Expenses of -$2.6 million for Q4 2022, down 779.17% on a YoY basis from $385637.7 in Q4 2021, and down 176.32% sequentially from $3.4 million in Q3 2022.
NuCana (NCNA) Other Operating Expenses (2018 - 2022) Analysis & Trends
NuCana (NCNA) has 5 years of Other Operating Expenses data on file, last reported at -$2.6 million in Q4 2022.
- For the quarter ending Q4 2022, Other Operating Expenses fell 779.17% year-over-year to -$2.6 million; the trailing twelve-month figure through Sep 2023 stood at -$2.6 million (down 183.57% YoY), and the FY2022 full-year result was -$6.2 million, down 1246.3% from the prior year.
- Other Operating Expenses declined to -$2.6 million in Q4 2022, from $3.4 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $3.4 million in Q3 2022 to a low of -$2.6 million in Q4 2022.
- A 5-year average of $752740.5 and a median of $1.1 million in 2019 frame the typical range for Other Operating Expenses.
- Peak annual rise in Other Operating Expenses reached 95.41% in 2022, while the deepest fall reached 779.17% in 2022.
- Tracing NCNA's Other Operating Expenses over 5 years: stood at $920237.8 in 2018, then jumped by 64.44% to $1.5 million in 2019, then tumbled by 93.11% to $104302.4 in 2020, then plunged by 385.62% to -$297910.3 in 2021, then sank by 779.17% to -$2.6 million in 2022.
- Business Quant data shows NCNA's Other Operating Expenses at -$2.6 million in Q4 2022, $3.4 million in Q3 2022, and -$297910.3 in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | NuCana | 14.60 Bn | 14.60 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -2.62 Mn |
| Sep 30, 2022 | 3.43 Mn |
| Dec 31, 2021 | -297,910.34 |
| Sep 30, 2021 | 1.76 Mn |
| Jun 30, 2020 | 104,302.43 |
| Sep 30, 2019 | 1.51 Mn |
| Jun 30, 2019 | 1.21 Mn |
| Sep 30, 2018 | 920,237.78 |